159 related articles for article (PubMed ID: 17020154)
1. beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release.
Zaghloul AA
Pharmazie; 2006 Sep; 61(9):775-9. PubMed ID: 17020154
[TBL] [Abstract][Full Text] [Related]
2. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
4. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.
Zaghloul AA; Mustafa F; Siddiqui A; Khan M
Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848
[TBL] [Abstract][Full Text] [Related]
5. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable microparticulates of beta-estradiol: preparation and in vitro characterization.
Zaghloul AA; Mustafa F; Siddiqu A; Khan M
Drug Dev Ind Pharm; 2005 Sep; 31(8):803-11. PubMed ID: 16221615
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
[TBL] [Abstract][Full Text] [Related]
8. The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.
Sezer AD; Akbuğa J
Pharm Dev Technol; 2012; 17(1):118-24. PubMed ID: 20977313
[TBL] [Abstract][Full Text] [Related]
9. Effect of processing temperature on Eudragit RS PO microsphere characteristics in the solvent evaporation process.
Sahoo SK; Dhal S; Mohapatro P; Behera BC; Barik BB
Pharmazie; 2007 Aug; 62(8):638-9. PubMed ID: 17867564
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of the fibronectin central cell binding domain from polymeric microspheres.
Bouissou C; Potter U; Altroff H; Mardon H; Van Der Walle C
J Control Release; 2004 Mar; 95(3):557-66. PubMed ID: 15023466
[TBL] [Abstract][Full Text] [Related]
11. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
Hu FQ; Wu MZh; Yuan H; Zhang HH
Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
[TBL] [Abstract][Full Text] [Related]
12. Thymosin-loaded enteric microspheres for oral administration: preparation and in vitro release studies.
Yang JF; Qiu LY; Jin Y; Zhang JX
Int J Pharm; 2005 Sep; 301(1-2):41-7. PubMed ID: 16009514
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent.
Zhang Y; Zhang Y; Guo S; Huang W
Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382
[TBL] [Abstract][Full Text] [Related]
14. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug.
Sahana DK; Mittal G; Bhardwaj V; Kumar MN
J Pharm Sci; 2008 Apr; 97(4):1530-42. PubMed ID: 17722098
[TBL] [Abstract][Full Text] [Related]
15. Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.
Srivastava AK; Ridhurkar DN; Wadhwa S
Acta Pharm; 2005 Sep; 55(3):277-85. PubMed ID: 16375838
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
[TBL] [Abstract][Full Text] [Related]
17. Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of zidovudine.
Mandal TK; Shekleton M; Onyebueke E; Washington L; Penson T
J Microencapsul; 1996; 13(5):545-57. PubMed ID: 8864992
[TBL] [Abstract][Full Text] [Related]
18. Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release.
Mandal B; Halder KK; Dey SK; Bhoumik M; Debnath MC; Ghosh LK
Pharmazie; 2009 Jul; 64(7):445-9. PubMed ID: 19694181
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
Mathew ST; Devi SG; KV S
AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
Devrim B; Canefe K
Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
